Does the addition of drugs targeting the vascular endothelial growth factor pathway to first-line chemotherapy increase complete response? A meta-analysis of randomized clinical trials

Clinical Trials ◽

Growth Factor ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Complete Response ◽

Vascular Endothelial ◽

First Line ◽

Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) does not increase the incidence of venous thromboembolism when added to first-line chemotherapy to treat metastatic colorectal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3529 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3529-3529 ◽

Cited By ~ 1

Author(s):

W. F. Novotny ◽

E. Holmgren ◽

B. Nelson ◽

R. Mass ◽

F. Kabbinavar ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Venous Thromboembolism ◽

Growth Factor ◽

Metastatic Colorectal Cancer ◽

Vascular Endothelial ◽

First Line ◽

Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer

BMC Cancer ◽

10.1186/1471-2407-9-421 ◽

2009 ◽

Vol 9 (1) ◽

Cited By ~ 5

Author(s):

Sachin Kumar ◽

Randeep Guleria ◽

Vikas Singh ◽

Alok C Bharti ◽

Anant Mohan ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Vascular Endothelial ◽

Small Cell Lung ◽

First Line ◽

Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor

Oncology Reports ◽

10.3892/or.14.2.481 ◽

2005 ◽

Author(s):

Seock-Ah Im ◽

Sung-Bae Kim ◽

Moon Lee ◽

Young-Hyuck Im ◽

Kyung Lee ◽

...

Keyword(s):

Growth Factor ◽

Phase Ii ◽

Phase Ii Trial ◽

Extracellular Domain ◽

Vascular Endothelial ◽

First Line ◽

Predictive Values ◽

Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) does not increase the incidence of venous thromboembolism when added to first-line chemotherapy to treat metastatic colorectal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3529 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3529-3529 ◽

Cited By ~ 4

Author(s):

W. F. Novotny ◽

E. Holmgren ◽

B. Nelson ◽

R. Mass ◽

F. Kabbinavar ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Venous Thromboembolism ◽

Growth Factor ◽

Metastatic Colorectal Cancer ◽

Vascular Endothelial ◽

First Line ◽

Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2014.11.006 ◽

2015 ◽

Vol 93 (3) ◽

pp. 257-276 ◽

Cited By ~ 19

Author(s):

Pooja Ghatalia ◽

Youjin Je ◽

Nemer El Mouallem ◽

Paul L. Nguyen ◽

Quoc-Dien Trinh ◽

...

Keyword(s):

Clinical Trials ◽

Receptor Tyrosine Kinase ◽

Randomized Clinical Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Tyrosine Kinase Inhibitors

Complete response after treatment with first-line targeted anti-vascular endothelial growth factor therapy in metastatic renal cancer: what next?

Annals of Translational Medicine ◽

10.21037/atm.2016.06.25 ◽

2016 ◽

Vol 4 (15) ◽

pp. 291-291

Author(s):

Emanuele Zaffuto ◽

Pierre I. Karakiewicz ◽

Umberto Capitanio

Keyword(s):

Growth Factor ◽

Renal Cancer ◽

Complete Response ◽

Vascular Endothelial ◽

First Line ◽

Metastatic Renal Cancer ◽

Factor Therapy ◽

Growth Factor Therapy ◽

Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2020.103186 ◽

2021 ◽

Vol 157 ◽

pp. 103186

Author(s):

Avash Das ◽

Somnath Mahapatra ◽

Dhrubajyoti Bandyopadhyay ◽

Santanu Samanta ◽

Sandipan Chakraborty ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Vascular Endothelial ◽

Association of the Vascular Endothelial Growth Factor Gene Polymorphisms (-460C/T, +405G/C and +936T/C) with Endometriosis: A Meta-Analysis

Annals of Human Genetics ◽

10.1111/j.1469-1809.2012.00726.x ◽

2012 ◽

Vol 76 (6) ◽

pp. 464-471 ◽

Cited By ~ 13

Author(s):

Shaohua Xu ◽

Wei Wu ◽

Hong Sun ◽

Jing Lu ◽

Beilei Yuan ◽

...

Keyword(s):

Growth Factor ◽

Gene Polymorphisms ◽

Meta Analysis ◽

Vascular Endothelial ◽

Factor Gene ◽

Growth Factor Gene ◽

From the discovery of Vascular Endothelial Growth Factor to the introduction of Avastin in clinical trials - an interview with Napoleone Ferrara

The International Journal of Developmental Biology ◽

10.1387/ijdb.103216dr ◽

2011 ◽

Vol 55 (4-5) ◽

pp. 383-388 ◽

Cited By ~ 16

Author(s):

Domenico Ribatti

Keyword(s):

Clinical Trials ◽

Growth Factor ◽

Vascular Endothelial ◽

Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype

Journal of Medical Genetics ◽

10.1136/jmg.2008.058222 ◽

2008 ◽

Vol 46 (12) ◽

pp. 840-846 ◽

Cited By ~ 46

Author(s):

D Lambrechts ◽

K Poesen ◽

R Fernandez-Santiago ◽

A Al-Chalabi ◽

R Del Bo ◽

...

Keyword(s):

Amyotrophic Lateral Sclerosis ◽

Growth Factor ◽

Meta Analysis ◽

Vascular Endothelial ◽

Male Carriers ◽

Lateral Sclerosis ◽

Increased Susceptibility